Icahn School of Medicine at Mount Sinai Continues Drive to Diversify Research by Appointing New Biomedical Laureates
Will help advance research in diabetes treatment and vaccine effectiveness
The Icahn School of Medicine at Mount Sinai announced today the appointment of two new Laureates as part of its Biomedical Laureates Program, bringing the total to five appointments for this year and furthering its institutional commitment to broadening faculty diversity and mentorship opportunities.
“We are thrilled to welcome these two fantastic researchers to Icahn Mount Sinai. With each new biomedical laureate, the Health System brings new eyes and ears to critically important areas of medicine—in this case, diabetes research and vaccine development—and new opportunities to be truly diverse and inclusive in biomedical research,” says Eric J. Nestler, MD, PhD, Nash Family Professor of Neuroscience, Director of The Friedman Brain Institute, and Dean for Academic Affairs, Icahn Mount Sinai, and Chief Scientific Officer, Mount Sinai Health System.
“And with each new laureate, our system is better equipped to fulfill its mission to provide safe, compassionate and equitable care to the diverse patient communities we serve,” adds Dr. Nestler, an early champion of the Biomedical Laureates program.